A Comparison of Labetalol and Nitroglycerin for The Management of Intraoperative Hypertension in Ambulatory Surgical Patients Who Underwent Cataract Surgery

  • Mehdi Sanatkar Department of Anesthesiology, Farabi eye hospital, Tehran University of medical sciences, Tehran, Iran.
  • Hossein Sadrossadat Department of Anesthesiology, Farabi eye hospital, Tehran University of medical sciences, Tehran, Iran.
  • Mehrdad Goudarzi Department of Anesthesiology, Farabi eye hospital, Tehran University of medical sciences, Tehran, Iran.
  • Ebrahim Espahbodi Department of Anesthesiology, Farabi eye hospital, Tehran University of medical sciences, Tehran, Iran.
  • Masoumeh Zangeneh Department of Anesthesiology, Farabi eye hospital, Tehran University of medical sciences, Tehran, Iran.
Keywords: Labetalol, Nitroglycerin, Intraoperative hypertension, Cataract surgery

Abstract

Background: This is a prospective randomized blinded clinical trial comparing the efficacy and safety of labetalol and nitroglycerin for the management of intraoperative hypertension in ambulatory surgical patients who underwent cataract surgery. Methods: A total of 80 hypertensive patients (systolic blood pressure> 200 mmHg or diastolic blood pressure>100 mmHg) who had increased blood pressure during cataract surgery under topical anesthesia were reviewed. Patients were randomized to receive nitroglycerin (group N, n=40) or labetalol (group L, n=40). The initial dose of nitroglycerin was a bolus of 2 µg/kg and repeat dose of 1ug/kg intravenously every 5 minutes. Labetalol was administered as a bolus of 5 mg followed by 5 mg intravenously as needed every five minutes up to maximum dose of 1 mg/kg. Results: Systolic blood pressure decreased from 21.4±8.6 mm Hg (200 to 260 mm Hg) to 18.8±6.4 mm Hg with administration of nitroglycerin. Labetalol reduced systolic blood pressure from 21.4±6.7 mm Hg (201 to 258 mm Hg) to 17.6±11.6 (p=0.02). Nitroglycerin increased baseline heart rate from 68±8 beats/min to 82±6 beats/min (p=0.04), however, in the labetalol group heart rate reduced from control 72±6 to 64±9 beats/min (P<0.05). The hypotension episode was 18 (45%) cases in the nitroglycerin group and 2 (5%) cases in the labetalol group respectively (p<0.05). The mean of systolic blood pressure during their stay in the recovery room in nitroglycerin group was 20.7±9.6 mm Hg and in labetalol group was 18.5±10.2 mm Hg (p<0.05). Conclusion: Nitroglycerin may produce reflex tachycardia and episode of hypotension especially in elderly patients intraoperatively. Labetalol is a safe and effective antihypertensive agent for management of increased blood pressure during cataract surgery with topical anesthesia.

References

1. Bollinger KE, Langston RH. What can patients expect from cataract surgery? Cleve Clin J Med. 2008; 75(3):193-6, 199-200.
2. Yap YC, Woo WW, Kathirgamanathan T, Kosmin A, Faye B, Kodati S. Variation of blood pressure during topical phacoemulsification. Eye (Lond). 2009; 23(2):416-20.
3. Sajedi P, Nejad MS, Montazeri K, Baloochestani E. Comparing the preventive effect of 2 percent topical lidocaine and intravenous atropine on oculocardiac reflex in ophthalmological surgeries under general anesthesia. Int J Prev Med. 2013; 4(11):1258-65.
4. Sabanayagam C, Wang JJ, Mitchell P, Tan AG, Tai ES, Aung T, Saw SM, Wong TY. Metabolic syndrome components and age-related cataract: the Singapore Malay eye study. Invest Ophthalmol Vis Sci. 2011; 52(5):2397-404.
5. Bae I, Lim HM, Hur MH, Lee M. Intra-operative music listening for anxiety, the BIS index, and the vital signs of patients undergoing regional anesthesia. Complement Ther Med. 2014; 22(2):251-7.
6. MacCarthy EP, Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy. 1983; 3(4):193-219.
7. Rodrigo C. Induced hypotension during anesthesia with special reference to orthognathic surgery. Anesth Prog. 1995;42(2):41-58. Review.
8. Meftahuzzaman SM, Islam MM, Ireen ST, Islam MR, Kabir H, Rashid H, Uddin MZ. Comparison of efficacy of labetalol and fentanyl for attenuating reflex responses to laryngoscopy and intubation. Mymensingh Med J. 2014; 23(2):242-8.
9. Gollogly HE, Hodge DO, St Sauver JL, Erie JC. Increasing incidence of cataract surgery: population-based study. J Cataract Refract Surg. 2013; 39(9):1383-9.
10. Fromme GA, MacKenzie RA, Gould AB Jr, Lund BA, Offord KP. Controlled hypotension for orthognathic surgery. Anesth Analg. 1986; 65(6):683-6.
11. Das A, Mukherje A, Chhaule S, Chattopadhyay S, Halder PS, Mitra T, Basunia SR, Mandal SK. Induced hypotension in ambulatory functional endoscopic sinus surgery: A comparison between dexmedetomidine and clonidine as premedication. A prospective, double-blind, and randomized study. Saudi J Anaesth. 2016; 10(1):74-80.
12. Tobias JD. Controlled hypotension in children: a critical review of available agents. Paediatr Drugs. 2002; 4(7):439-53.
13. Baker AR, Baker AB. Anaesthesia for endoscopic sinus surgery. Acta Anaesthesiol Scand. 2010; 54(7):795-803. Review.
14. Scott DB. The use of labetalol in anaesthesia. Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):133S-135S.
15. Srivastava U, Dupargude AB, Kumar D, Joshi K, Gupta A. Controlled hypotension for functional endoscopic sinus surgery: comparison of esmolol and nitroglycerine. Indian J Otolaryngol Head Neck Surg. 2013; 65(Suppl 2):440-4.
16. Singh PP, Dimich I, Sampson I, Sonnenklar N. A comparison of esmolol and labetalol for the treatment of perioperative hypertension in geriatric ambulatory surgical patients. Can J Anaesth. 1992; 39(6):559-62.
17. Wilson DJ, Wallin JD, Vlachakis ND, Freis ED, Vidt DG, Michelson EL, Langford HG, Flamenbaum W, Poland MP. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. Am J Med. 1983; 75(4A):95-102.
18. Leslie JB, Kalayjian RW, Sirgo MA, Plachetka JR, Watkins WD. Intravenous labetalol for treatment of postoperative hypertension. Anesthesiology. 1987; 67(3):413-6.
19. Sirivanasandha B, Sakaew A, Sutthivaiyakit K, Raksamani K, Waitayawinyu P, Rushatamukayanunt P, Punkla W. An Equivalence Trial Comparing Labetalol and Diltiazem in Controlling Emergence Hypertension after Supratentorial Tumor Surgery. J Med Assoc Thai. 2015; 98(11):1104-11.
20. Webster LM, Myers JE, Nelson-Piercy C, Harding K, Cruickshank JK, Watt-Coote I, Khalil A, Wiesender C, Seed PT, Chappell LC. Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial. Hypertension. 2017; 70(5):915-922.
21. Patel P, Koli D, Maitra N, Sheth T, Vaishnav P. Comparison of Efficacy and Safety of Intravenous Labetalol Versus Hydralazine for Management of Severe Hypertension in Pregnancy. J Obstet Gynaecol India. 2018; 68(5):376-381.
22. Webster LM, Webb AJ, Chappell LC. What is the evidence for using labetalol as a first-line treatment option for hypertension in pregnancy? Drug Ther Bull. 2018; 56(9):107-111.
Published
2018-12-29
How to Cite
1.
Sanatkar M, Sadrossadat H, Goudarzi M, Espahbodi E, Zangeneh M. A Comparison of Labetalol and Nitroglycerin for The Management of Intraoperative Hypertension in Ambulatory Surgical Patients Who Underwent Cataract Surgery. Arch Anesth & Crit Care. 5(1):15-7.
Section
Research Article(s)